Home โบ Kidney Cancer
Kidney Cancer clinical trials recruiting in the U.S.
61 studies for Kidney Cancer are recruiting participants at sites across the United States.
Kidney cancer symptoms are hard to detect at first but they do exist. Read more about the top 5 symptoms and the treatment options available
Cities with the most studies
- New York City, NY16 studies
- Boston, MA13 studies
- Nashville, TN12 studies
- Houston, TX11 studies
- San Diego, CA10 studies
- Washington, DC9 studies
- St. Louis, MO9 studies
- Dallas, TX9 studies
- Rochester, MN8 studies
- Jacksonville, FL8 studies
- Edison, NJ8 studies
- Seattle, WA8 studies
- Baltimore, MD7 studies
- Miami, FL7 studies
- Los Angeles, CA7 studies
- Phoenix, AZ6 studies
- Cleveland, OH6 studies
- Portland, OR6 studies
- Omaha, NE6 studies
- Baldwin Park, CA6 studies
- Durham, NC6 studies
- Mountain View, CA6 studies
- Queens, NY6 studies
- Aurora, CO6 studies
- Denver, CO5 studies
- Columbus, OH5 studies
- Staten Island, NY5 studies
- New Rochelle, NY5 studies
- Pittsburgh, PA5 studies
- Orange, CA4 studies
- Chicago, IL4 studies
- Arlington, VA4 studies
- Highlands Ranch, CO4 studies
- Louisville, KY4 studies
- New Haven, CT4 studies
- Atlanta, GA4 studies
- Detroit, MI4 studies
- San Antonio, TX4 studies
- East Norwalk, CT4 studies
- Oklahoma City, OK3 studies
By state
- Arizona9 studies
- Arkansas3 studies
- California20 studies
- Colorado10 studies
- Connecticut6 studies
- Florida15 studies
- Georgia6 studies
- Illinois8 studies
- Indiana4 studies
- Iowa4 studies
- Kentucky4 studies
- Louisiana3 studies
- Maryland16 studies
- Massachusetts15 studies
- Michigan6 studies
- Minnesota11 studies
- Missouri10 studies
- Nebraska6 studies
- New Jersey8 studies
- New York17 studies
- North Carolina8 studies
- Ohio11 studies
- Oklahoma4 studies
- Oregon6 studies
- Pennsylvania10 studies
- South Carolina5 studies
- Tennessee12 studies
- Texas19 studies
- Virginia7 studies
- Washington8 studies
- Wisconsin6 studies
Recently updated studies
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT00033137Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
RecruitingObservational studyHealthy volunteers welcome
4 Weeks ยท All sexes ยท Updated Sep 28, 2026 ยท NCT01109394Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecruitingObservational study
Ages 18 and older ยท All sexes ยท Updated Sep 25, 2026 ยท NCT04981119A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Sep 25, 2026 ยท NCT07401875NSAID Use After Robotic Partial Nephrectomy
RecruitingPhase 2
Ages 18 to 99 ยท All sexes ยท Updated Sep 24, 2026 ยท NCT05842044Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA
RecruitingPhase 2
Ages 18 to 75 ยท All sexes ยท Updated Sep 18, 2026 ยท NCT07828704A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Sep 18, 2026 ยท NCT07688187Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA
RecruitingPhase 2
Ages 18 to 75 ยท All sexes ยท Updated Sep 18, 2026 ยท NCT06948552Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Sep 17, 2026 ยท NCT07227415Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older ยท All sexes ยท Updated Sep 16, 2026 ยท NCT00050752Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Sep 9, 2026 ยท NCT05287945Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
Recruiting
Ages 18 and older ยท All sexes ยท Updated Sep 3, 2026 ยท NCT06138067Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 2, 2026 ยท NCT07011719A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Aug 31, 2026 ยท NCT05536141Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older ยท All sexes ยท Updated Aug 28, 2026 ยท NCT00026884Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older ยท All sexes ยท Updated Aug 24, 2026 ยท NCT00001238A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Aug 20, 2026 ยท NCT07123090[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
RecruitingPhase 1
Ages 18 to 120 ยท All sexes ยท Updated Aug 18, 2026 ยท NCT06479811A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Aug 11, 2026 ยท NCT07195682Distance-Based Exercise to Preserve Function and Prevent Disability
Recruiting
Ages 18 and older ยท All sexes ยท Updated Aug 5, 2026 ยท NCT07059884Study of XmAbยฎ819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Aug 3, 2026 ยท NCT05433142Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Aug 3, 2026 ยท NCT07300241A Study of a Side Effects and Resource Navigation Program for People With Cancer
Recruiting
Ages 18 and older ยท All sexes ยท Updated Jul 31, 2026 ยท NCT07646847Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
RecruitingPhase 1/2
Ages 18 to 100 ยท All sexes ยท Updated Jul 29, 2026 ยท NCT05665361Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Jul 21, 2026 ยท NCT07062549From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.